| abstract |
The invention concerns an oligosaccharide comprising uronic acid repeating unitsnhaving an average molecular weight by weight comprised between 1,200 and 3,000 Dnand containing nitro groups -ONO 2 covalently bonded to the saccharide structure, andnpharmaceutical compositions comprising it. n The oligosaccharide according to the invention is disclosed for use as a medicament,nmore specifically for use in the treatment and prevention of pathologies associated withndisfunctions of haemostatic and cardiovascular systems. |